Perspective Therapeutics, Inc. 8-K

What Happened

• Perspective Therapeutics, Inc. (CATX) filed a Current Report on Form 8-K on June 1, 2026 (Item 8.01) to disclose an updated corporate presentation.
• The presentation is filed as Exhibit 99.1 and is incorporated by reference into the 8-K. The report was signed by Joel Sendek, Chief Financial Officer.

Key Details

• Filing date: June 1, 2026.
• Exhibit filed: 99.1 — Corporate Presentation.
• Cover page interactive data: Exhibit 104 (Inline XBRL) is included.
• Report signed by Joel Sendek, CFO, on behalf of the company.

Why It Matters

• An updated corporate presentation is the company’s public investor material and may contain refreshed information on strategy, pipeline, milestones, or financial highlights. Retail investors should review Exhibit 99.1 on SEC EDGAR to see any substantive updates.
• This 8-K does not report earnings, an executive change, or a merger; it simply provides updated investor presentation materials for review.